EMILY TICE: Open Payments
NPI 1972070548 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$403 in 19 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $183 · 2025 $403
Food & beverage: $403
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $88 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $56 |
| Novo Nordisk Inc | 2 | $56 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Boston Scientific Corporation | 1 | $34 |
| Seqirus USA Inc | 1 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| SANOFI-AVENTIS U.S. LLC | 1 | $17 |
| Abbott Laboratories | 1 | $15 |
Products named: VRAYLAR, REXULTI, WATCHMAN FLX, Flucelvax, Ozempic, TRINTELLIX, Rybelsus, JARDIANCE.
Industry payments across TN — which companies pay providers there.
